Worth reading
55In focus
Scored from 2 of 5 sectionsDirection
Neutral
Direction inferred from the company’s description.Scale
1890000
SharesWording
Definitive
How definitive the wording is.Details of issuance or disposal
Designation to suspend exercise of fixed exercise price Stock Acquisition Rights
発行・処分する株式数
1,890,000 shares (18,900 rights)
Intended allottee
Cantor Fitzgerald Europe（CFE）
Terms of the stock acquisition rights
Exercise price
Only that the exercise price is fixed is stated. Amount is Not disclosed
Number of Stock Acquisition Rights
18,900 rights subject to the designation
Most recent equity financing
25 June 2026: Issuance of Series 8 to Series 10 Stock Acquisition Rights (fixed exercise price). Amount is Not disclosed
| Item | Details |
|---|---|
| Type of issuance or disposal | Designation to suspend exercise of fixed exercise price Stock Acquisition Rights |
| Number of shares to be issued or disposed of | 1,890,000 shares (18,900 rights) |
| Intended allottee | Cantor Fitzgerald Europe（CFE） |
| Exercise price | Only that the exercise price is fixed is stated. Amount is Not disclosed |
| Number of Stock Acquisition Rights | 18,900 rights subject to the designation |
| Most recent equity financing | 25 June 2026: Issuance of Series 8 to Series 10 Stock Acquisition Rights (fixed exercise price). Amount is Not disclosed |
Items this document does not state (22)
Issue price and disposal priceTotal issue valueAmount of funds to be raisedEstimated issuance expensesSpecific use of fundsPayment dateIntended allottee's holding policyDilution RateTotal number of issued sharesBasis for determining the amount to be paidExercise periodTransfer restriction periodConditions for lifting transfer restrictionsReason for acquisition without considerationCategories and Number of Persons CoveredTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioProcedures under the Corporate Code of ConductMajor shareholders after the offeringImpact on Business Performance
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The disclosure states that a designation to suspend exercise was made, but does not state the reason.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.